Jung-Woo Park

Jung-Woo Park

Auto-generated profile, based on publicly available information

Jung-Woo Park

Department of Obstetrics and Gynecology, Dong-A University, College of Medicine, Busan, Republic of Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Reproductive Toxicology
Verified
Journal Article
Closed access
YCYeon Jean Cho
Yeon Jean Cho
SPSeung Bin Park
Seung Bin Park
JPJung Woo Park
Jung Woo Park
SOSo Ra Oh
So Ra Oh
MHMyoungseok Han
Myoungseok Han

1 January 2017 in Obstetrics & Gynecology Science
Verified
Journal Article
Open access
SLSeung Hyun Lee
Seung Hyun Lee
JPJung-Woo Park
Jung-Woo Park
SOSo Ra Oh
So Ra Oh
SRSeo Hee Rha
Seo Hee Rha
Müllerianosis is an embryonic Müllerian disease, resulting in the formation of the benign diseases adenomyosis, endometriosis, endosalpingiosis, and endocervicosis. Endocervicosis primarily affects the bladder, and rarely the cervix. Cervical endocervicosis, which is also a pseudoneoplastic glandular lesion, could be misinterpreted as a premalignant or even a malignant lesion. Because the treatment of these diseases is very different, early clinical diagnosis is important. Unfortunately, however, this lesion is difficult to diagnose preoperatively using clinical and radiological information, and pathological confirmation is needed. Herein, we report a rare case of cervical endocervicosis that was difficult to diagnosis preoperatively.

4 December 2019 in Molecular and Clinical Oncology
Verified
Journal Article
Open access
PDF file
SLSEUNG HYUN LEE
SEUNG HYUN LEE
JBJong Woon Bae
Jong Woon Bae
MHMyoungseok Han
Myoungseok Han
YCYeon Jean Cho
Yeon Jean Cho
JPJung‑Woo Park
Jung‑Woo Park
YLYongmin Lee
Yongmin Lee
The aim of the present study was to compare the oncological outcome of nerve‑sparing radical hysterectomy (NSRH) and conventional radical hysterectomy (CRH) for early‑stage cervical cancer using a meta‑analysis. A systematic review and meta‑analysis was conducted, including 4 randomized controlled trials (RCT), 8 case‑control and 11 comparative cohort studies comparing the morbidity, pelvic dysfunctions and oncological outcome between the two surgical methods. A total of 23 studies were included in this meta‑analysis. The studies reported data of patients affected by cervical cancer; were written in English; included ≥20 patients; and reported data of patients with a comparison of clinical outcomes between NSRH and CRH. Data were extracted and risk of bias was assessed by four independent reviewers. A total of 1,796 patients were included: 884 patients (49.2%) undergoing NSRH and 912 (50.8%) undergoing CRH. The meta‑analyses were conducted using Review Manager version 5.3 software, which is designed for conducting Cochrane reviews. As regards perioperative parameters, NSRH was found to be associated with a lower intraoperative blood loss and a shorter length of hospital stay in comparison with CRH. Patients undergoing NSRH experienced lower incidence of urinary, colorectal and sexual dysfunction compared with patients undergoing CRH. However, the resected parametrial width was favorable in patients with CRH, suggesting that NSRH was inferior to CRH in terms of radicality. The 5‑year disease‑free and overall survival rates were similar between the two groups. In this systematic review and meta‑analysis, the collected data to date demonstrated that the nerve‑sparing approach guarantees minimized surgical‑related pelvic dysfunction, with similar oncological outcomes as CRH. However, further RCTs should be conducted to confirm the superiority and safety of NSRH.

10 November 2016 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
PDF file
SLSeung Hyun Lee
Seung Hyun Lee
JPJung‐Woo Park
Jung‐Woo Park
MHMyoungseok Han
Myoungseok Han
JBJong Woon Bae
Jong Woon Bae
YCYeon Jean Cho
Yeon Jean Cho

10 January 2025 in Medicine
Verified
Journal Article
Open access
SPSoyoung Park
Soyoung Park
JPJung-Woo Park
Jung-Woo Park
SRSeo-Hee Rha
Seo-Hee Rha
SKSujin Kim
Sujin Kim
Rationale: Malignant melanoma is a rare cancer that accounts for approximately 1% of all cancers. Primary malignant melanoma of the female genital tract accounts for approximately 3% to 7% of all malignant melanomas, and 0.3% to 0.8% of all melanomas in women. It affects postmenopausal women ages 60 to 80 years. Various hormonal factors, including puberty, pregnancy, menopause, oral contraceptive use, and human papillomavirus infection are associated with primary malignant melanoma of the vagina. Patient concerns: Symptoms often include vaginal bleeding, discharge, and pain; however, it can also present as pigmented or nonpigmented lesions, making diagnosis challenging. Diagnoses: Diagnosis involves detailed history, physical examination, and imaging (CT, MRI, and positron emission tomography). Immunohistochemical staining for markers, such as human melanoma black-45 and Melan-A, is crucial for confirmation. The diagnosis was made through careful physical examination, imaging studies, and immunohistochemistry. Interventions: The treatment includes wide local excision, radical surgery, radiotherapy, chemotherapy, and immunotherapy. The prognosis of primary malignant melanoma of the vagina is usually poor owing to late diagnosis, and the 5-year survival rate is 5% to 25%. Outcomes and lessons: To consider the possibility of primary malignant melanoma of vagina, postmenopausal women, particularly those who with human papillomavirus infection, should be performed thorough examination regardless of symptoms of vaginal bleeding or discharge.

4 August 2023 in Medicine
Verified
Journal Article
Open access
HCHwa Yeon Choi
Hwa Yeon Choi
MPMin Gyoung Pak
Min Gyoung Pak
JPJung-Woo Park
Jung-Woo Park
Rationale: Carcinoid tumors, derived from the cells of the disseminated neuroendocrine system, are rare, slow-growing neuroendocrine neoplasms that display a relatively indolent disease course. The majority of carcinoids are found within the gastrointestinal tract and bronchopulmonary system. Primary ovarian carcinoids are rare and account for merely 1% of all carcinoid tumors. We describe our experience of a rare case of primary ovarian carcinoid, presenting as chronic constipation, with no other carcinoid symptoms such as flushing, diarrhea, and wheezing. Patient concerns: A 51-year-old postmenopausal woman with chronic constipation visited the clinic for routine check-up of her preexisting uterine fibroids. She had undergone hemorrhoidectomy 3 years ago. Physical examination revealed a soft abdomen without direct or rebound tenderness. Transvaginal ultrasonography revealed two subserosal fibroids, which had increased in size compared with previous ultrasonographic findings. A 3 cm hyperechoic mass was also detected in the right ovary. Her blood and urine tests were unremarkable, with no ascites in the pelvic cavity. She had a normal CA-125 level of 5.5 units/mL. Diagnosis, interventions, and outcomes: The patient underwent a robot-assisted hysterectomy and right salpingo-oophorectomy because of enlarging fibroids and the right ovarian mass. Subsequently, based on the pathological and immunohistochemical findings, she was diagnosed with a primary ovarian carcinoid. The mass consisted of the insular and trabecular types of tumor cells. It was positive for pan-cytokeratin and synaptophysin, and the Ki-67 proliferation index was less than 1%. A follow-up positron emission tomography-computed tomography revealed no distant metastasis. Six months postoperatively, the patient was doing well without any signs of recurrence. Lessons: Primary ovarian carcinoids without teratoma components are rare. It is crucial to make an accurate diagnosis based on the immunohistochemical staining results. Diagnosis in the early stages of the disease are associated with a favorable prognosis, but regular follow-up is mandatory.